Computational researchers and oncologists develop protein cancer atlas to accelerate personalized medicine for leukemia patients
Thursday, 18 April 2019
by utsaengineer
(April 17, 2019) — Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis. To improve that survival rate, researchers at UTSA and the University of Texas MD Anderson Cancer Center created an online atlas to identify and classify protein signatures present at AML diagnosis. The
- Published in Biomedical Engineering, COE Announcements, News, UTSA COE
No Comments